PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New advance against a form of heart failure prevalent in men

New advance against a form of heart failure prevalent in men
2024-04-01
(Press-News.org)

University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that contributes to the greater incidence of heart failure in men. 

Y chromosome loss in men occurs progressively throughout life and can be detected in approximately 40% of 70-year-old men. UVA’s Kenneth Walsh, PhD, discovered in 2022 that this loss can contribute to heart muscle scarring and lead to deadly heart failure. (That finding was the first to directly link Y chromosome loss to a specific harm to men’s health; Y chromosome loss is increasingly thought to play a role in diseases ranging from Alzheimer’s to cancer.)

In an important follow-up finding, Walsh and his team have discovered how Y chromosome loss triggers changes in heart immune cells that make the cells more likely to cause scarring and heart failure.

Further, the researchers found they could reverse the harmful heart changes by giving lab mice a drug that targets the process of fibrosis that leads to the heart scarring, which could lead to a similar treatment for men.

“Our previous work identified that it was loss of the entire Y chromosome that contributed to heart disease in men,” said Walsh, the director of UVA’s Hematovascular Biology Center. “This new work identified a single gene on the Y chromosome that can account for the disease-promoting effects of Y chromosome loss.”

About Y Chromosome Loss

Unlike women, who have two X chromosomes, men have an X and a Y. For a long time, the genes found on the Y chromosome were not thought to play important roles in disease. Sex hormones, scientists thought, explained the differences in certain diseases in men and women. But Walsh’s groundbreaking work has helped change that perception. It also suggested an explanation for why heart failure is more common in men than women. (Cardiovascular disease, which includes heart failure, is the leading cause of death worldwide.)

Y chromosome loss occurs in only a small percentage of affected men’s cells. This results in what is called “mosaicism”, where genetically different cells occur within one individual. Researchers aren’t entirely sure why this partial Y chromosome loss occurs, but predominantly it strikes elderly men and men who smoke compared to those who don’t. 

To better understand the effects of Y chromosome loss, Walsh and his team examined genes found on the Y chromosome to determine which might be important to heart scarring. One gene they looked at, Uty, helps control the operating instructions for immune cells called macrophages and monocytes, the scientists determined. When the Uty gene was disrupted, either individually or through Y chromosome loss, that triggered changes in the immune cells in lab mice. Suddenly, the macrophages were much more “pro-fibrotic,” or prone to scarring. This accelerated heart failure as well, the scientists found.

“The identification of a single gene on the Y chromosome provides information about a new druggable target to treat fibrotic diseases,” said Walsh, of UVA’s Division of Cardiovascular Medicine and Robert M. Berne Cardiovascular Research Center. 

Walsh and his team were able to prevent the harmful changes in the mice’s macrophages by giving them a specially designed monoclonal antibody. This halted the harmful changes in the heart, suggesting the approach might, with further research, lead to a way to treat or avoid heart failure and other fibrotic diseases in men with Y chromosome loss.

“Currently, we are working with our clinician colleagues in the Division of Cardiovascular Medicine at UVA to assess whether loss of the Y chromosome in men is associated with greater scarring in the heart,” Walsh said. “This research will provide new avenues for understanding the causes of heart disease.”

Based on their findings, Walsh and his team believe that a small group of genes found on the Y chromosome may have big effects on a wide array of diseases. Their new work identifies mechanisms that may lead to this, and they are hopeful that further research will provide a much better understanding of unknown causes of sickness and death in men.

“This research further documents the utility of studying the genetics of mutations that are acquired after conception and accumulate throughout life,” Walsh said. “These mutations appear to be as important to health and lifespan as the mutations that are inherited from one’s parents. The study of these age-acquired mutations represents a new field of human genetics.” 

Findings Published

The researchers have published their findings in the scientific journal Nature Cardiovascular Research. The team consisted of Keita Horitani, Nicholas W. Chavkin, Yohei Arai, Ying Wang, Hayato Ogawa, Yoshimitsu Yura, Megan A. Evans, Jesse Cochran, Mark C. Thel, Ariel H. Polizio, Miho Sano, Emiri Miura-Yura, Yuka Arai, Heather Doviak, Arthur P. Arnold, Bradley D. Gelfand, Karen K. Hirschi, Soichi Sano and Walsh. The scientists have no financial interest in the work.

The research was supported by the National Institutes of Health, grants AG073249, HL142650 and HL152174; the National Aeronautics and Space Administration, grant 80NSSC21K0549; the UVA Medical Scientist Training Program, grant T32GM007267; the American Heart Association, grant 23CDA1054358; Grant-in-Aid for Research Activity Start-up grants 21K20879 and 22K08162; the Japanese Heart Failure Society; the Japanese Circulation Society; the Japan Cardiovascular Research Foundation; the SENSHIN Medical Research Foundation; the MSD Life Science Foundation; Novartis; the Kondou Kinen Medical Foundation; and the Bayer Scholarship for Cardiovascular Research.

To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog at http://makingofmedicine.virginia.edu.

 

END


[Attachments] See images for this press release:
New advance against a form of heart failure prevalent in men

ELSE PRESS RELEASES FROM THIS DATE:

Canton wins Wayne Bardin International Travel Award

2024-04-01
WASHINGTON—The Endocrine Society selected Ana Canton, M.D., Ph.D., as the recipient of its 2024 C. Wayne Bardin, MD, International Travel Award for her outstanding ENDO abstract and her research contributions to the care of patients with pediatric endocrine disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne Bardin, who made remarkable research contributions to both reproductive physiology and contraception throughout his long career. As the winner, ...

Memorial Sloan Kettering Cancer Center experts to present leading-edge research at the American Association for Cancer Research Annual Meeting 2024

Memorial Sloan Kettering Cancer Center experts to present leading-edge research at the American Association for Cancer Research Annual Meeting 2024
2024-04-01
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California. MSK experts will present significant research and will be available to comment on topics including cancer metastasis, immunology, molecular biology and genetics, and early drug development. Vinod Balachandran, MD, will present updates on personalized RNA neoantigen vaccines in pancreatic cancer ...

Kennedy Krieger publishes major national research and guidance on pediatric autism

2024-04-01
BALTIMORE, April 1, 2024— Researchers at Kennedy Krieger Institute are sharing their expertise on autism spectrum disorder in a medical journal reaching thousands of pediatric professionals worldwide. The journal, Pediatric Clinics, provides the latest clinical information on health and related issues for children and adolescents. The newly released volume is titled "Pediatric Management of Autism." This issue features five original articles written by 10 faculty members from the Institute. Each contribution investigates crucial aspects of caring for children with autism, offering actionable insights. Dr. Paul ...

Canada lynx historic range in US likely wider than previously thought

Canada lynx historic range in US likely wider than previously thought
2024-04-01
PULLMAN, Wash. – A broader past could mean a brighter future for Canada lynx in the U.S., according to recent research. The study, published in the journal Biological Conservation, indicates that lynx might do well in the future in parts of Utah, central Idaho and the Yellowstone National Park region, even considering climate change and the lack of lynx in those areas now. Using a model validated by historic records, researchers first found that in 1900, Canada lynx had more suitable habitat in the U.S. than the few northern corners of the country where they are found currently. The study showed ...

Study documents safety, improvements from stem cell therapy after spinal cord injury

Study documents safety, improvements from stem cell therapy after spinal cord injury
2024-04-01
ROCHESTER, Minn. — A Mayo Clinic study shows stem cells derived from patients' own fat are safe and may improve sensation and movement after traumatic spinal cord injuries. The findings from the phase 1 clinical trial appear in Nature Communications. The results of this early research offer insights on the potential of cell therapy for people living with spinal cord injuries and paralysis for whom options to improve function are extremely limited. In the study of 10 adults, the research team noted seven participants demonstrated ...

Simple equations clarify cloud climate conundrum

Simple equations clarify cloud climate conundrum
2024-04-01
New analysis based on simple equations has reduced uncertainty about how clouds will affect future climate change. Clouds have two main effects on global temperature – cooling the planet by reflecting sunlight, and warming it by acting as insulation for Earth’s radiation.  The impact of clouds is the largest area of uncertainty in global warming predictions. In the new study, researchers from the University of Exeter and the Laboratoire de Météorologie Dynamique in Paris created a model that predicts how ...

A high-boost and high-efficiency DC power converter

A high-boost and high-efficiency DC power converter
2024-04-01
A new electrical power converter design achieves a much higher efficiency at lower cost and maintenance than before. The direct current voltage boost converter developed by Kobe University is poised to be a significant contribution to the further development of electric and electronic components across power generation, health care, mobility and information technology. Devices that harvest energy from sunlight or vibrations, or power medical devices or hydrogen-fueled cars have one key component in common. This so-called “boost converter” converts low-voltage direct current input into high-voltage direct current output. Because it is such a ubiquitous ...

Study suggests high blood pressure could begin in childhood

2024-04-01
Study suggests high blood pressure may originate early in life and that preventing overweight and obesity during the developmental years could help reduce the substantial disease burden associated with high blood pressure in later life. *This is an early press release from the European Congress on Obesity (ECO 2024) Venice 12-15 May. Please credit the Congress if using this material* Children and teenagers living with overweight or obesity are more likely to have high blood pressure as adults (aged 50-64 years), suggesting the processes behind the condition could begin as early as childhood, suggests new research being ...

Study finds association between TB infection and increased risk of various cancers

2024-04-01
**Note: the release below is a special early release from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, Spain, 27-30 April). Please credit the congress if you use this story** A population-wide observational study to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows an association between tuberculosis (TB) and cancer, with those with current or previous TB more likely ...

Swedish study indicates a significant decline of neutralising antibodies to monkeypox virus already during the first month after vaccination

2024-03-30
Previous smallpox vaccination contributes significantly to higher neutralising antibodies following first MVA-BN dose **Note: the release below is a special early release from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, Spain, 27-30 April). Please credit the congress if you use this story** New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 ...

LAST 30 PRESS RELEASES:

Rugged Falklands landscape was once a lush rainforest

Dizziness in older adults is linked to higher risk of future falls

Triptans more effective than newer, more expensive migraine drugs

Iron given through the vein corrects iron deficiency anaemia in pregnant women faster and better than iron taken by mouth

The Lancet Neurology: Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from st

Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth

Levels of protection from different cycle helmets revealed by new ratings

Pupils with SEND continue to fall behind their peers

Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits

Study first to link operating room design to shorter surgery

New study uncovers therapeutic inertia in the treatment of women with multiple sclerosis

Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer

Nawaz named ASME Fellow

U2opia signs license to commercialize anomaly-detection technology for cybersecurity

Explaining dramatic planetwide changes after world’s last ‘Snowball Earth’ event

Cleveland Clinic study is first to show success in treating rare blood disorder

Bone marrow cancer drug shows success in treatment of rare blood disorder

Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder

UVA Engineering professor awarded $1.6M EPA grant to reduce PFAS accumulation in crops

UVA professor receives OpenAI grant to inform next-generation AI systems

New website helps researchers overcome peer reviewers’ preference for animal experiments

Can the MIND diet lower the risk of memory problems later in life?

Some diabetes drugs tied to lower risk of dementia, Parkinson’s disease

Propagated corals reveal increased resistance to bleaching across the Caribbean during the fatal heatwave of 2023

South African rock art possibly inspired by long-extinct species

Even marine animals in untouched habitats are at risk from human impacts

Hexagonal electrohydraulic modules shape-shift into versatile robots

Flexible circuits made with silk and graphene on the horizon

Scott Emr and Wesley Sundquist awarded 2024 Horwitz Prize for discovering the ESCRT pathway

Versatile knee exo for safer lifting

[Press-News.org] New advance against a form of heart failure prevalent in men